Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...

Almirall, a global pharmaceutical company dedicated to medical dermatology hosts the 16th edition of Skin Academy, a premier conference for healthcare professionals in the field of dermatology. This ...

The researchers highlighted that psoriasis is a systemic condition linked to various comorbidities, emphasizing the ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended remissions and protection against PsA relative to other biologics.

Whether you’re just starting psoriasis treatment or are looking for more effective therapies for your symptoms, it helps to remember these important steps to take — and to avoid. If you’re ...

More than half of patients with fingernail psoriasis achieved complete fingernail clearance after 68 weeks of guselkumab treatment.

Nique Clifford's 2024 NBA draft decision came down to literally the final moments as he chose between a flight to Indianapolis to continue the draft process or one home to return to college.

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Arcutis is a rare topical dermatology player with accelerating launch metrics and continued growth. Read more about the ...

Alumis Inc.'s twice-a-day oral drug totally cleared the skin of telltale red, itchy patches in nearly 39% of 80 ...

Two-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an ...

The World Health Organization (WHO) is offering the option of voluntary early retirement to eligible employees as it seeks to cut costs following US President Donald Trump’s decision to withdraw from ...